Van Stuivenberg; Herman H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Van Stuivenberg; Herman H..The latest application filed is for "bifeprunox derivatives".

Company Profile

0.17.17

Van Stuivenberg; Herman H. - Weesp NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1H-imidazole derivatives as cannabinoid CB2 receptor modulators Grant 8,937,184 - Lange , et al. January 20, 2	2015-01-20
1H-imidazole derivative having CB.sub.1, agonistic, CB.sub.1 partial agonistic or CB.sub.1 antagnistic activity Grant 8,729,101 - Kruse , et al. May 20, 2	2014-05-20
Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors Grant 8,067,603 - Den Hartog , et al. November 29, 2	2011-11-29
Bifeprunox Derivatives App 20110105523 - Van Stuivenberg; Herman H. ; et al.	2011-05-05
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors Grant 7,851,630 - Den Hartog , et al. December 14, 2	2010-12-14
1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity Grant 7,745,476 - Lange , et al. June 29, 2	2010-06-29
4,5-dihydro-1H-pyrazole derivatives having potent CB.sub.1-antagonistic activity Grant 7,608,718 - Lange , et al. October 27, 2	2009-10-27
1h-imidazole Derivative Having Cb1, Agonistic, Cb1 Partial Agonistic Or Cb1 Antagnistic Activity App 20090181949 - KRUSE; Cornelis G. ; et al.	2009-07-16
4,5-dihydro-1H-pyrazole derivatives having CB.sub.1-antagonistic activity Grant 7,528,162 - Kruse , et al. May 5, 2	2009-05-05
1 H-imidazole derivatives as cannabinoid receptor modulators Grant 7,498,348 - Lange , et al. March 3, 2	2009-03-03
Imidazoline derivatives having CB.sub.1-antagonistic activity Grant 7,495,108 - Lange , et al. February 24, 2	2009-02-24
Thiazole derivatives having CB.sub.1-antagonistic, agonistic or partial agonistic activity Grant 7,342,032 - Lange , et al. March 11, 2	2008-03-11
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB.sub.1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity Grant 7,319,110 - Lange , et al. January 15, 2	2008-01-15
1 H-imidazole Derivatives As Cannabinoid Receptor Modulators App 20070281974 - Lange; Josephus H.M. ; et al.	2007-12-06
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity App 20070259884 - Lange; Josephus H.M. ; et al.	2007-11-08
1H-imidazole derivatives as cannabinoid receptor modulators Grant 7,271,189 - Lange , et al. September 18, 2	2007-09-18
Neurotensin active 2,3,diaryl-pyrazolidine derivatives Grant 7,186,741 - Feenstra , et al. March 6, 2	2007-03-06
Imidazoline derivatives having CB.sub.1-antagonistic activity Grant 7,173,044 - Lange , et al. February 6, 2	2007-02-06
Imidazoline derivatives having CB1-antagonistic activity App 20060241152 - Lange; Josephus H.M. ; et al.	2006-10-26
1H-imidazole derivatives as cannabinoid CB2 receptor modulators App 20060194779 - Lange; Josephus H.M. ; et al.	2006-08-31
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity Grant 6,974,810 - Lange , et al. December 13, 2	2005-12-13
Imidazoline derivatives having CB1-antagonistic activity App 20050187259 - Lange, Josephus H.M. ; et al.	2005-08-25
1H-imidazole derivatives as cannabinoid receptor modulators App 20050137197 - Lange, Josephus H.M. ; et al.	2005-06-23
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors App 20050075355 - Den Hartog, Jacobus A.J. ; et al.	2005-04-07
Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors App 20050070528 - Den Hartog, Jacobus A.J. ; et al.	2005-03-31
1 H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity App 20050054679 - Kruse, Cornelis G. ; et al.	2005-03-10
Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity App 20040266841 - Lange, Josephus H.M. ; et al.	2004-12-30
Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity App 20040248944 - Kruse, Cornelis G ; et al.	2004-12-09
Neurotensin active 2,3,diaryl-pyrazolidine derivatives App 20040242493 - Feenstra, Roelof W. ; et al.	2004-12-02
1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity App 20040235854 - Kruse, Cornelis G. ; et al.	2004-11-25
4,5-Dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity App 20040106800 - Lange, Josephus H.M. ; et al.	2004-06-03
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity App 20040106614 - Lange, Josephus H. M. ; et al.	2004-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.